Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Intracranial Arteriosclerosis

3,4-methylenedioxyamphetamine has been researched along with Intracranial Arteriosclerosis in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
RUDORFER, L1
HANKOFF, LD1
PALEY, HM1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Intracranial Arteriosclerosis

ArticleYear
RANGE OF DEPRESSION: STUDY OF 244 DEPRESSED PATIENTS.
    New York state journal of medicine, 1963, Nov-01, Volume: 63

    Topics: Adolescent; Antisocial Personality Disorder; Anxiety; Brain; Brain Damage, Chronic; Depression; Depr

1963